Rare Skin Blistering Condition Gets First Drug Approved
(MedPage Today) -- Credit: B.E.L.A. butterfly children
The FDA granted the first drug approval for dystrophic epidermolysis bullosa (DEB), a topical gene therapy that treats the blistering wounds it causes, the agency announced Friday.
The...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Children | Epidermolysis Bullosa | Gene Therapy | Genetics | International Medicine & Public Health | Skin